Search results
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 2 days agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million ...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 2 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via AOL· 2 days ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 2 days agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
Guru Focus· 11 hours agoOn May 2, 2024, Moderna Inc (MRNA, Financial) filed its 10-Q report, revealing a challenging quarter with a stark decrease in revenue and a shift from profitability to a net ...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 1 day agoThis downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines. During Q1 2023, Moderna
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 2 days agoModerna's programs cover infectious diseases, oncology, cardiovascular diseases, and rare genetic...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agoModerna is rivaling vaccine makers Pfizer and Novavax. Still, the market for Covid boosters is...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo Finance· 2 days agoModerna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 2 days agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...